A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia (original) (raw)

• Mesa RA, Verstovsek S, Cervantes F, Barosi G, Reilly JT, Dupriez B et al. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res 2007, (in press); [Eh pub ahead of print, 6 January 2007].
• Tefferi A . Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342: 1255–1265.
  Article CAS Google Scholar
• Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A . Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 2005; 105: 973–977.
  Article CAS Google Scholar
• Devine SM, Hoffman R, Verma A, Shah R, Bradlow BA, Stock W et al. Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 2002; 99: 2255–2258.
  Article CAS Google Scholar
• Guardiola P, Anderson JE, Bandini G, Cervantes F, Runde V, Arcese W et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European group for blood and marrow transplantation, Societe francaise de greffe de moelle, Gruppo Italiano per il trapianto del midollo osseo, and Fred Hutchinson cancer research center collaborative study. Blood 1999; 93: 2831–2838.
  CAS PubMed Google Scholar
• Mesa RA . Myelofibrosis with myeloid metaplasia: therapeutic options in 2003. Curr Hematol Rep 2003; 2: 264–270.
  PubMed Google Scholar
• Tefferi A, Lasho TL, Mesa RA, Pardanani A, Ketterling RP, Hanson CA . Lenalidomide therapy in del(5)(q31)-associated primary or post-polycythemia vera myelofibrosis. Leukemia 2007, (in press); [E-pub ahead of print, 26 April 2007].
• Tefferi A, Cortes J, Verstovsek S, Mesa RA, Thomas D, Lasho TL et al. Lenalidomide therapy in myelofibrosis with myeloid metaplasia. Blood 2006; 108: 1158–1164.
  Article CAS Google Scholar
• End DW, Smets G, Todd AV, Applegate TL, Fuery CJ, Angibaud P et al. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res 2001; 61: 131–137.
  CAS PubMed Google Scholar
• Gibbs JB, Oliff A . The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Annu Rev Pharmacol Toxicol 1997; 37: 143–166.
  Article CAS Google Scholar
• Beaupre DM, Kurzrock R . RAS and leukemia: from basic mechanisms to gene-directed therapy. J Clin Oncol 1999; 17: 1071–1079.
  Article CAS Google Scholar
• Rowinsky EK, Windle JJ, Von Hoff DD . Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development. J Clin Oncol 1999; 17: 3631–3652.
  Article CAS Google Scholar
• Adjei AA . Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93: 1062–1074.
  Article CAS Google Scholar
• Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175–185.
  Article CAS Google Scholar
• Karp JE, Kaufmann SH, Adjei AA, Lancet JE, Wright JJ, End DW . Current status of clinical trials of farnesyltransferase inhibitors. Curr Opin Oncol 2001; 13: 470–476.
  Article CAS Google Scholar
• Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K et al. Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial. Blood 2001; 97: 3361–3369.
  Article CAS Google Scholar
• Lancet JE, Gojo I, Gotlib J, Feldman EJ, Greer J, Liesveld JL et al. A phase II study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood 2007; 109: 1387–1394.
  Article CAS Google Scholar
• Harousseau JL, Lancet JE, Reiffers J, Lowenberg B, Thomas X, Huguet F et al. A phase II study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. Blood 2007, (in press); [E-pub ahead of print, 9 March 2007].
• Mesa RA, Tefferi A, Gray LA, Reeder T, Schroeder G, Kaufmann SH . In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia. Leukemia 2003; 17: 849–855.
  Article CAS Google Scholar
• Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT et al. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006; 108: 1497–1503.
  Article CAS Google Scholar
• Yoon SY, Li CY, Mesa RA, Tefferi A . Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1999; 106: 682–688.
  Article CAS Google Scholar
• Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A . Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000; 96: 3374–3380.
  CAS PubMed Google Scholar
• English D, Andersen BR . Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll–Hypaque. J Immunol Methods 1974; 5: 249–252.
  Article CAS Google Scholar
• Mesa RA, Tefferi A, Gray LA, Reeder T, Schroeder G, Kaufmann SH . In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia. Leukemia 2003; 17: 849–855.
  Article CAS Google Scholar
• Vodoff MV, Nelken B, Vic P, Farriaux JP . Therapy of polycythemia vera in a 11 year old child [French]. Archives de Pediatrie 1996; 3: 870–873.
  Article CAS Google Scholar
• Dingli D, Schwager SM, Mesa RA, Li CY, Tefferi A . Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system. Cancer 2006; 106: 623–630.
  Article Google Scholar
• Kurzrock R, Albitar M, Cortes JE, Estey EH, Faderl SH, Garcia-Manero G et al. Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome. J Clin Oncol 2004; 22: 1287–1292.
  Article CAS Google Scholar
• Mesa RA, Nagorney DS, Schwager S, Allred J, Tefferi A . Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic. Cancer 2006; 107: 361–370.
  Article Google Scholar
• Fenaux P, Raza A, Mufti GJ, Aul C, Germing U, Kantarjian H et al. A multicenter phase II study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome. Blood 200; 109: 4158–4162.
  Article Google Scholar
• James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.
  Article CAS Google Scholar
• Baxter EJ, Scott LM, Campbell PJ et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.
  Article CAS Google Scholar
• Levine RL, Wadleigh M, Cools J . Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myelofibrosis with myeloid metaplasia. Cancer Cell 2005; 7: 387–397.
  Article CAS Google Scholar
• Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.
  Article CAS Google Scholar
• Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li CY et al. The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 2005; 131: 320–328.
  Article CAS Google Scholar